Hippo信号通路破坏与不孕患者卵巢卵泡激活
本文综述Hippo信号通路在卵巢卵泡生长中的作用及机械应力相关证据,描述卵巢破碎联合Akt刺激药物(体外激活,IVA)治疗早发性卵巢功能不全,以及无药物IVA治疗近期闭经的早发性卵巢功能不全、卵巢储备减退的中年女性和腹腔镜卵巢切开治疗抵抗性卵巢综合征。
要点
- Hippo通路破坏致YAP核转位,上调CCN生长因子和BIRC凋亡抑制因子,促进卵泡生长。
- 卵巢破碎增加肌动蛋白聚合,诱导YAP核转位,增强卵泡生长。
- 无药物IVA对近期闭经的早发性卵巢功能不全及卵巢储备减退中年女性可促进卵泡生长。
核心结论
- 机械应力在卵巢卵泡生长中起作用,卵巢破碎联合或不联合Akt刺激药物可激活卵泡用于不孕治疗。
- 基于腹腔镜卵巢切开的体内卵泡激活方法对抵抗性卵巢综合征显示应用前景。
- 作者认为未来研究可评估优化机械方法及局部给予肌动蛋白聚合增强药物用于卵巢不孕治疗的可能性。
研究设计与样本
- 综述,总结Hippo信号通路调控器官大小及卵巢卵泡生长的证据,并描述卵巢损伤性操作治疗卵巢性不孕的近期应用。
主要发现
- 果蝇至哺乳动物存在Hippo信号通路,破坏后YAP核转位增加,表达富含半胱氨酸61、结缔组织生长因子和肾母细胞瘤过表达(CCN)生长因子及含杆状病毒凋亡抑制重复序列(BIRC)凋亡抑制因子,增加器官大小。
- 昆虫细胞全基因组敲低显示肌动蛋白聚合促进YAP核转位。
- 哺乳动物卵巢表达Hippo信号通路基因,卵巢破碎增加肌动蛋白聚合,导致YAP核转位及富含半胱氨酸61、CCN生长因子和BIRC凋亡抑制因子表达增加,随后卵泡生长增强。
- 卵巢破碎联合体外孵育Akt刺激药物构成体外激活(IVA)疗法,用于治疗早发性卵巢功能不全患者;单独卵巢破碎(无药物IVA)成功治疗近期月经停止的早发性卵巢功能不全患者。
- 对卵巢反应差和卵巢储备减退的中年女性,无药物IVA也有效促进卵泡生长以治疗不孕;基于腹腔镜卵巢切开的体内卵泡激活方法对抵抗性卵巢综合征患者显示应用前景。
临床怎么用
- 卵巢破碎联合Akt刺激药物的IVA疗法可用于治疗早发性卵巢功能不全患者。
- 无药物IVA(单独卵巢破碎)可用于治疗近期月经停止的早发性卵巢功能不全患者。
- 无药物IVA可用于卵巢反应差和卵巢储备减退的中年女性,促进卵泡生长以治疗不孕。
- 基于腹腔镜卵巢切开的体内卵泡激活方法对抵抗性卵巢综合征患者显示应用前景。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The Hippo signaling pathway, which is important in organ size regulation, is present in organisms from the fly to mammals. Disruption of the Hippo signaling pathway leads to increased nuclear translocation of the effector Yes-associated protein (YAP), resulting in the expression of cystein-rich 61, connective tissue growth factor, and nephroblastoma overexpressed (CCN) growth factors and baculoviral inhibitors of apoptosis repeat containing (BIRC) apoptosis inhibitors to increase organ sizes. Furthermore, genome-wide knockdown of genes in insect cells demonstrated that actin polymerization promoted nuclear translocation of YAP. In the mammalian ovary, we demonstrated the expression of Hippo signaling pathway genes and showed that ovarian fragmentation increased actin polymerization, leading to YAP nuclear translocation and increased expression of cystein-rich 61, CCN growth factors and BIRC apoptosis inhibitors, followed by enhanced follicle growth. Here we summarize evidence suggesting the role of mechanical stress on follicle growth in the ovary and describe recent use of ovary-damaging procedures to treat ovarian infertility. Ovarian fragmentation, together with in vitro incubation with Akt-stimulating drugs, formed the basis of an in vitro activation (IVA) therapy to treat patients with premature ovarian insufficiency, whereas ovarian fragmentation alone (drug-free IVA) was successful in treating patients with premature ovarian insufficiency with recent menses cessation. For middle-aged women with poor ovarian responses and diminished ovarian reserve, drug-free IVA was also effective in promoting follicle growth for infertility treatment. In addition, an in vivo follicle activation approach based on laparoscopic ovarian incision showed promise for patients with resistant ovary syndrome. With initial success using mechanical disruption approaches, future investigation could evaluate possibilities to refine mechanical methods and to locally administer actin polymerization-enhancing drugs for ovarian infertility treatment.
引用
- Hsueh AJW, Kawamura K. Hippo signaling disruption and ovarian follicle activation in infertile patients. Fertil Steril. 2020. PMID: 32782158. doi:10.1016/j.fertnstert.2020.07.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。